PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Liquidia Corporation

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Liquidia Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

Where $100 of sales goes

$132Operating costs$15Interest$44Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-6.5×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Higher than 54% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

2/3 · 1/3

Sales grew in 2 of the last 3 years; profit grew in 1 of 3.

Less steady than 51% of Healthcare companies in United States.

Growth Efficiency Ratio

−$20

Sales grew 894% in 3 years, but profit fell: $20 less profit per $100 of extra sales.

Lower than 76% of Healthcare companies in United States.

Asset Productivity Ratio

+894% / +154%

In 3 years sales changed by +894% while total assets changed by +154%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

-0.6×

Operating cash was negative last year, while some debt falls due within a year.

Higher than 67% of Healthcare companies in United States.

Cash Cushion Ratio

−0%

Debt, after subtracting cash, equals 0% of its market value (net debt).

Lower than 68% of Healthcare companies in United States.

Tangible Assets Ratio

98%

Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 84% of Healthcare companies in United States.

Tangible Net Worth Ratio

85%

Of every $100 of net worth, $85 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 65% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+35%

Share count rose 35% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 50% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Liquidia Corporation owes $0.63 for every $1 it owns. Liquidia Corporation made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

28.6

Investors pay $28.6 for every $1 of Liquidia Corporation's yearly profit, higher than 55% of Healthcare companies in United States.

P/B ratio

18.21

The share price is 18.21 times Liquidia Corporation's book value per share, higher than 93% of Healthcare companies in United States.

Market cap

$3.6 B

The total market value of all of Liquidia Corporation's shares at today's price (share price × number of shares), larger than 81% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$195 M

What Liquidia Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$2.18

Net worth divided by the number of shares. The share price of $39.69 is 18.2 times this, which is the P/B above.

Return on equity (ROE)

131.8%

Liquidia Corporation earned 131.8% on its shareholders' money over the last year, higher than almost all Healthcare companies in United States.

Owes vs Owns

0.63×

Liquidia Corporation owes $0.63 for every $1 it owns (moderate), higher than 66% of Healthcare companies in United States.

Dividend yield

None

Liquidia Corporation does not currently pay a dividend.

Revenue growth

+1031%

Revenue rose 1031% in the year to Dec 2025, and grew 115% a year on average over 3 years.

Profit growth

Loss

Liquidia Corporation made a loss in each of the last two years.

Profit margin

-43.5%

Liquidia Corporation lost $44 for every $100 of revenue.

Interest cover

Not covered

Liquidia Corporation's operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

Liquidia Corporation had $7 M more debt than cash (net debt) at Dec 2025.

Questions

What is Liquidia Corporation's P/E ratio?

Investors pay $28.6 for every $1 of Liquidia Corporation's yearly profit, higher than 55% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Liquidia Corporation: $3.6 B ÷ $195 M (30 Jun 2026) = 18.2.

What is Liquidia Corporation's return on equity?

Liquidia Corporation earned 131.8% on its shareholders' money over the last year, higher than almost all Healthcare companies in United States.

How much does Liquidia Corporation owe compared with what it owns?

Liquidia Corporation owes $0.63 for every $1 it owns (moderate), higher than 66% of Healthcare companies in United States.

Does Liquidia Corporation pay a dividend?

No. Liquidia Corporation does not currently pay a dividend.

Is Liquidia Corporation's revenue growing?

Revenue rose 1031% in the year to Dec 2025, and grew 115% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.